Publications & Abstracts
A Pilot Study of the Duodenal-Jejunal Bypass Liner in Low Body Mass Index Type 2 Diabetes
To assess the safety of the DJBL and to evaluate its potential to affect glycemic control beneficially in subjects with T2DM who were not morbidly...
Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner
The purpose of this study was to evaluate the effect of the duodenal–jejunal bypass liner (DJBL), a 60-cm, impermeable fluoropolymer liner anchored...
Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner
To evaluate safety, weight loss, and cardiometabolic changes in obese subjects implanted with the duodenal-jejunal bypass liner (DJBL) for 1...
Six Month Results of a Multi-Center, Prospective, Randomized Trial of the Endoscopic Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes in Obese Subjects
This is an interim report of an ongoing one year study. In a prospective, randomized, diet controlled, multicentre study, 77 subjects were included,...
Mechanisms for Improved Glycemic Control After Endoscopically Placed Duodenal-Jejunal Bypass Line
To investigate glycemic control and the underlying mechanisms of the Duodenal Jejunal Bypass Liner (DJBL).
Implantation of the Duodenal-Jejunal Bypass Sleeve Under Conscious Sedation: A Case Series
The duodenal-jejunal bypass liner has been evaluated in clinical studies of patients with morbid obesity, where it has been shown to result in...
Initial Human Experience with Restrictive Duodenal-Jejunal Bypass Liner for Treatment of Morbid Obesity
The aim of the present study was to evaluate the clinical effects and safety of the duodenal-jejunal bypass liner combined with a restrictor orifice...
Open-Label, Sham-Controlled Trial of an Endoscopic Duodenojejunal Bypass Liner for Preoperative Weight Loss in Bariatric Surgery Candidates
This 12-week, open-label, randomized trial investigated the use of the DJBL versus a sham upper endoscopy for weight loss before bariatric...
Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes
Obese T2DM subjects were randomized to receive a DJBL (n ¼ 12) or sham endoscopy (n ¼ 6) in a 24-week study, extended up to 52 weeks.
An Endoluminal Sleeve Induces Substantial Weight Loss and Normalizes Glucose Homeostasis in Rats with Diet-Induced Obesity
To investigate the contributions of two surgical gut manipulations—exclusion of the proximal intestine from alimentary flow and exposure of the...